title: Role of synthesized organoselenium compounds on protection of rat erythrocytes from DMBA-induced oxidative stress.
abstract: Formation of free radicals is not limited to normal cellular process but also occur upon exposure to certain chemicals (polycyclic aromatic hydrocarbon, cadmium, lead, etc.), cigarette smoke, radiation, and high-fat diet. Free-radical damage is an important factor in many pathological and toxicological processes. Selenium, an essential micronutrient, is a associated with antioxidant functions, physiological defense mechanisms against different diseases including several types of cancers. Search for new selenium compounds with more chemopreventive activities and less toxicities are in progress. In addition, there has been a growing interest in the synthesis of organoselenium compounds with respect to their use in enzymology and bioorganic chemistry. In the present study, adult female Wistar rats were treated with 7,12-dimethylbenz[a]anthracene (DMBA) and the organoselenium compounds [1-isopropyl-3-methylbenzimidazole-2-selenone (Se I) and 1, 3-di-p-methoxybenzylpyrimidine-2-selenone (Se II)] in determined doses. The protective effects of synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in antioxidant enzyme (superoxide dismutase, glutathione peroxidase (GSH-Px), catalase (CAT), glutathione reductase (GR)) activities, total GSH, and malondialdehyde (MDA) levels of rat erythrocyte were investigated. The DMBA-treated group exhibited significant decreases in the levels of erythrocyte GSH-Px, CAT, and GR activities, an increase in MDA levels, and a decrease in total GSH level compared to the control. Se I and Se II fully or partially restored enzyme activity. Lipid peroxidation was also decreased in Se-I- and Se-II-treated groups.
authors.affiliation: Department of Biology, Faculty of Arts and Science, Nigde University, Nigde, Turkey. ztalas@nigde.edu.tr
authors.forename: Zeliha
authors.initials: Z
authors.lastname: Selamoglu Talas
authors.forename: Ismet
authors.initials: I
authors.lastname: Yilmaz
authors.forename: Ilknur
authors.initials: I
authors.lastname: Ozdemir
authors.forename: Burhan
authors.initials: B
authors.lastname: Ates
authors.forename: Yetkin
authors.initials: Y
authors.lastname: Gok
authors.forename: Bekir
authors.initials: B
authors.lastname: Cetinkaya
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity; D000818:Animals; D000975:Antioxidants / Q000737:chemistry / Q000494:pharmacology*; D001562:Benzimidazoles / Q000737:chemistry / Q000494:pharmacology*; D002273:Carcinogens / Q000633:toxicity; D019610:Cytoprotection; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D015227:Lipid Peroxidation / Q000187:drug effects; D016566:Organoselenium Compounds / Q000737:chemistry / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects*; D011743:Pyrimidines / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: C526938:1,3-di-p-methoxybenzylpyrimidine-2-selenone; C526937:1-isopropyl-3-methylbenzimidazole-2-selenone; D000975:Antioxidants; D001562:Benzimidazoles; D002273:Carcinogens; D016566:Organoselenium Compounds; D011743:Pyrimidines; D015127:9,10-Dimethyl-1,2-benzanthracene